资讯

Proper legal structuring is essential when it comes to transferring Chinese biotech intellectual property and clinical assets ...
Experts at PA Consulting offer case studies and advice for using generative AI to improve biopharma manufacturing, mitigate ...
After decades of racing to the bottom on pricing, a revolution is coming to the U.S. generics market, writes Yaral Pharma CEO ...
The European Union (EU) is actively courting biotech for economic growth and has launched several initiatives to attract ...
Advocacy for alternatives to animal testing in clinical research is pushing the industry away from animal-based endotoxin ...
Experts at Faegre Drinker offer life sciences business planning and risk mitigation strategies to consider in response to enacted or anticipated policy changes under the Trump administration.
Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early and late-stage drug development, explains Halloran's Carolina Ahrendt.
Good mental health (MH) and psychological well-being are fundamental human concerns in determining human happiness and flourishing, both in private and working life. One of the most comprehensive and ...
It was the summer of 2007 when Chris Anzalone, Ph.D., got a call from Arrowhead Research Company. At the time, Anzalone was working as CEO of the Bennet Group, a private equity firm in Washington, D.C ...
Key innovation, technology, dealmaking and policy considerations are reshaping the industry’s future While patent expirations of $300b will continue to put pressure on growth, robust innovation likely ...
Biogen and Eisai’s codevelopment and copromotion deal in Alzheimer’s disease (AD), the most common type of dementia, is one of the most closely watched collaborations in the industry. Millions of ...
As anxiety disorders become more common and stress from the diverse impacts of the COVID-19 pandemic threaten the mental/emotional well-being of Americans everywhere, it is clear that the current ...